James Hill has over 10 years of experience in venture capital investing in healthcare information technology, financial technology, and enterprise software. Before joining Grand Ventures, he served as a Vice President of Venture Capital and Private Equity at First Trust Capital Partners. FTCP is the private investment arm of a $200B AUM asset manager with over 90 portfolio companies. During his time there, James led investments in a range of healthcare and fintech investments including Phynd (acquired by symplr), SteadyMD, TouchCare, ClinOne, Dina, ProofPilot, Circuit Clinical, Korio Clinical, and Flexwise. Prior to First Trust, he was a Vice President at Edison Partners. Edison is a growth-stage venture firm that is on its tenth fund and was primarily focused on fintech, digital health, and enterprise software. While there, James managed the digital health and fintech investment pipelines and led the Edison Director Network. He sourced and helped close more than ten growth-stage investments and served as a board director for multiple healthcare portfolio companies. Some of his investments include Clinverse (acquired by BioClinica), Trialscope (acquired by Informa), Solovis (acquired by Nasdaq), BlueMedora (acquired by VMware), ItemMaster (acquired by Gladson), Predata (acquired by FiscalNote), PurpleLab, Signet Accel, and Virtual Health. Before his investing career, he had experience working with IBM’s Watson Solutions applying natural language processing to healthcare, financial, and enterprise customer problems, and in law at Bryan Cave, LLP. James received an MBA in finance and JD focused on corporate law from Michigan State University and holds a BS in History from the University of Wisconsin-Madison.